Money Matters - Simplified

Clarient, Inc.: Warming Up or Cooling Off?

Together, we are all trying to build our fortune by
finding well-run companies at bargain-basement prices. But it
takes work -- scouring company earnings reports, scrutinizing
key data, and assessing the competition.

Because of that, we've created a screen based on the massive data
aggregated from the more than 140,000 investors competing on our Motley Fool CAPS
platform. Each quarter, we check in on select companies after they file
a 10-Q and track community sentiment -- so you can see how your company
is doing.

Here's the community sentiment on Clarient, Inc. (Nasdaq: CLRT) both this quarter and last (for comparison), as well as opinions on some related companies.

Metric Clarient, Inc. (Nasdaq: CLRT) Hospira, Inc. (NYSE: HSP) Kensey Nash Corp (Nasdaq: KNSY) ICU Medical, Inc. (Nasdaq: ICUI)
This Quarter (11/13/2009):
Price: $2.35 $47.70 $23.45 $35.09
% of Members Rating Outperform 89% 88% 84% 78%
% of All-Star Members Rating Outperform 88% 88% 62% 73%
CAPS Rating (out of 5) *** *** ** ****
Last Quarter (8/15/2009):
Price: $3.77 $40.09 $28.83 $36.17
% of Members Rating Outperform 86% 87% 84% 75%
% of All-Star Members Rating Outperform 82% 97% 80% 81%
CAPS Rating (out of 5) *** ***** **** ****

Source: Motley Fool CAPS. Dates given
are the posting dates of Clarient, Inc.'s most recent quarterly and/or
annual reports to the SEC's website. Percentages are calculated from
the number of members rating each company.

A change in the community's approval (signified by four- and five-star ratings)
or disapproval (one- and two-star ratings) could indicate that further
research is in order. To help make your research easier …

  • Share any thoughts you have about Clarient, Inc. -- or any of the other companies mentioned -- in the comments box below.
  • Head over to the completely free CAPS service -- a one-stop research shop -- and read what your fellow investors are saying about your stocks.

© 2009 UCLICK, L.L.C.